Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Lakartidningen|June 6, 2018
[Cervical cancer has increased in Sweden in women who had a normal cell sample]Joakim Dillner, Pär Sparén, Bengt Andrae, et al.
Acta Oncologica (Stockholm, Sweden)|May 19, 2020
Increase of cervical cancer incidence in Sweden in relation to screening history: population cohort studyJiangrong Wang, Bengt Andrae, Björn Strander, et al.
Acta Cytologica|June 2, 2021
Nationwide Rereview of Normal Cervical Cytologies before High-Grade Cervical Lesions or before Invasive Cervical CancerHenrik Edvardsson, Jiangrong Wang, Bengt Andrae, et al.
International Journal of Cancer|September 11, 2023
Long-term follow-up of cervical cancer incidence after normal cytological findingsJiangrong Wang, Henrik Edvardsson, Björn Strander, et al.
International Journal of Cancer|November 11, 2010
Risk of invasive cervical cancer in relation to clinical investigation and treatment after abnormal cytology: a population-based case-control studyLena Silfverdal, Levent Kemetli, Pär Sparén, et al.
American Journal of Obstetrics and Gynecology|June 30, 2009
Risk of invasive cervical cancer in relation to management of abnormal Pap smear resultsLena Silfverdal, Levent Kemetli, Bengt Andrae, et al.
Journal of the National Cancer Institute|May 1, 2008
Screening-preventable cervical cancer risks: evidence from a nationwide audit in SwedenBengt Andrae, Levent Kemetli, Pär Sparén, et al.
BMJ (Clinical Research Ed.)|March 3, 2012
Screening and cervical cancer cure: population based cohort studyBengt Andrae, Therese M-L Andersson, Paul C Lambert, et al.
Acta Obstetricia Et Gynecologica Scandinavica|August 20, 2009
Value of high-risk HPV-DNA testing in the triage of ASCUSIréne Silverloo, Bengt Andrae, Erik Wilander
Pageof 8